Booth No.4R-34

CategoryIngredients

PavilionChina Pavilion

EOS MED CHEM CO., LTD

Booth No.：4R-34

Category：Ingredients

Pavilion：China Pavilion

Company Information

Email： order@eosmedchem.com TEL： +86-531-6990-5422 Address： 250024
16F, China Overseas Plaza, Jinan City, China CHINA URL： http://www.eosmedchem.com

Contact in Japan

Japan agent： EOS MED CHEM CO., LTD Email： order@eosmedchem.com TEL： +86-531-6990-5422 Address： 16F, China Overseas Plaza, Jinan City, China

EOS mainly serving new drug research and development institutions including CRO institutions and scientific research institutes. The identification of candidates and other key aspects of new drug development.

EOS Medchem is big in: New API and Intermediates, Custom synthesis, ADC Drug

MG: Pharma Impurity

G: New small molecule and inhibitor

KG: New drug Intermediates

100KG: New chemical CMO

R&D Center: 4000 sq, More than 100 hoods

Pilot Plant: 20000sq, 40 reactors from 5-200L

Manufacturing Site: 800000sq, 40 reactors from 100-5000L

Web: www.eosmedchem.com

Email: info@eosmedchem.com ; eosmedchem@gmail.com;

R&D youtube: https://youtu.be/r5cJdXKNXHk

Company information

Address	250024 16F, China Overseas Plaza, Jinan City, China CHINA
TEL	+86-531-6990-5422
FAX	+86-531-6990-5422
URL	http://www.eosmedchem.com
Email	order@eosmedchem.com

Product introduction	(2460460-94-8)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate (2925289-44-5)(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-((3-aminophenethyl)(methyl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamide (1870916-87-2)6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(1S)-1-{[(1S)-1-[(4-(hydroxymethyl)phenyl)carbamoyl]ethyl]carbamoyl}-2-methylpropyl]hexanamide (2722698-01-1)tert-butyl (2-(4-amino-2-chlorophenethoxy)ethyl)(methyl)carbamate (1599440-07-9)[2-(Fmoc-amino)acetamido]Acetate-Cbz (2055041-41-1)NH-bis(PEG4-Boc);NH-bis(PEG4-t-butyl ester) (2460461-34-9)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate (916821-46-0)IRDye 700DX NHS Ester (1343407-91-9)Alloc-Val-Ala-PAB-OH (2050232-20-5)Belantamab Mafodotin (1346452-25-2)Enfortumab Vedotin (1313206-42-6)Polatuzumab vedotin (914088-09-8)Brentuximab vedotin (solution) (1702967-37-0)(2S)-2-({[(1S)-1-carboxy-5-[(2S)-3-(naphthalen-2-yl)-2-{[(1s,4s)-4-[(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl]cyclohexyl]formamido}propanamido]pentyl]carbamoyl}amino)pentanedioic acid (163768-52-3)benzyl (2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate (1260431-28-4)1,4-Dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone, 16-[(1S)-1-[(2R,3R)-3-[4-(aminomethyl)phenyl]-2-oxiranyl]ethyl]-10-[(3-chloro-4-methoxyphenyl)methyl]-6,6-dimethyl-3-(2-methylpropyl)-, (3S,10R,13E,16S)- (2847102-44-5)Calotatug ginistinag (1491917-83-9)Satralizumab Linker (2227102-46-5)Patritumab deruxtecan (2768350-77-0)Sacituzumab tirumotecan

Product introduction

(2460460-94-8)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate New

(2925289-44-5)(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-((3-aminophenethyl)(methyl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamide New

(1870916-87-2)6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(1S)-1-{[(1S)-1-[(4-(hydroxymethyl)phenyl)carbamoyl]ethyl]carbamoyl}-2-methylpropyl]hexanamide New

(2722698-01-1)tert-butyl (2-(4-amino-2-chlorophenethoxy)ethyl)(methyl)carbamate New

(1599440-07-9)[2-(Fmoc-amino)acetamido]Acetate-Cbz New

(2055041-41-1)NH-bis(PEG4-Boc);NH-bis(PEG4-t-butyl ester) New

(2460461-34-9)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate New

(916821-46-0)IRDye 700DX NHS Ester New

(1343407-91-9)Alloc-Val-Ala-PAB-OH New

(2050232-20-5)Belantamab Mafodotin New

(1346452-25-2)Enfortumab Vedotin New

(1313206-42-6)Polatuzumab vedotin New

(914088-09-8)Brentuximab vedotin (solution) New

(1702967-37-0)(2S)-2-({[(1S)-1-carboxy-5-[(2S)-3-(naphthalen-2-yl)-2-{[(1s,4s)-4-[(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl]cyclohexyl]formamido}propanamido]pentyl]carbamoyl}amino)pentanedioic acid New

(163768-52-3)benzyl (2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate New

(1260431-28-4)1,4-Dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone, 16-[(1S)-1-[(2R,3R)-3-[4-(aminomethyl)phenyl]-2-oxiranyl]ethyl]-10-[(3-chloro-4-methoxyphenyl)methyl]-6,6-dimethyl-3-(2-methylpropyl)-, (3S,10R,13E,16S)- New

(2847102-44-5)Calotatug ginistinag New

(1491917-83-9)Satralizumab Linker New

(2227102-46-5)Patritumab deruxtecan New

(2768350-77-0)Sacituzumab tirumotecan New

Contact in Japan

Japan Agent	EOS MED CHEM CO., LTD
Address	16F, China Overseas Plaza, Jinan City, China
TEL	+86-531-6990-5422
FAX	+86-531-6990-5422
Email	order@eosmedchem.com

Product introduction

(1870916-87-2)6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(1S)-1-{[(1S)-1-[(4-(hydroxymethyl)phenyl)carbamoyl]ethyl]carbamoyl}-2-methylpropyl]hexanamide New